Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of ETV5 as a prognostic marker related to epigenetic modification in pan-cancer and facilitates tumor progression in hepatocellular carcinoma

29 Nov 2024

Abstract excerpt

ETS variant transcription factor 5 (ETV5), a master transcription factor during development, exerts vital function on the occurrence and progression of various cancers. In order to systematically analyze and explore ETV5 potential specific regulatory mechanisms in pan-cancer, RNA sequencing data and clinicopathological features of patients with various tumors were obtained through the Cancer Genome Atlas (TCGA)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39614096
DOI: 10.1038/s41598-024-81642-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of ETV5 as a prognostic marker related to epigenetic modification in pan-cancer and facilitates tumor progression in hepatocellular carcinomaPMID 39614096Read ↗

E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and functionSemantic proximity Read ↗

Oncogenic role and drug sensitivity of ETV4 in human tumors: a pan-cancer analysisSemantic proximity Read ↗

ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progressionSemantic proximity Read ↗

E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanismsSemantic proximity Read ↗

The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progressionSemantic proximity Read ↗

Biological and prognostic value of ETV5 in high-grade serous ovarian cancerSemantic proximity Read ↗

The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer CellsSemantic proximity Read ↗

Clinical Significance and Regulation of ERK5 Expression and Function in CancerSemantic proximity Read ↗

Investigating a pathogenic role for TXNDC5 in tumors.Semantic proximity Read ↗

E2F8 is a Potential Therapeutic Target for Hepatocellular CarcinomaSemantic proximity Read ↗

Impact of SETD8/KMT5A Overexpression on Hepatocellular Carcinoma Progression and PrognosisSemantic proximity Read ↗

ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet‐derived growth factor BBSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.